You May Also Like

National ALS Registry newsletter ; winter 2022
Cite
CITE Title : National ALS Registry newsletter ; winter 2022 Corporate Authors(s) : National ALS Registry.;United States. Agency for Toxic Substances and Disease Registry.; Published Date : winter 2022 Series : National ALS Registry newsletter ; winter 2022 URL : https://stacks.cdc.gov/view/cdc/123048 National ALS Registry. (2022). National ALS Registry newsletter ; winter 2022. National ALS Registry. "National ALS Registry newsletter ; winter 2022" (2022) National ALS Registry. "National ALS Registry newsletter ; winter 2022" , 2022 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 2.85 MB]
:
National ALS Registry. ...
winter 2022 | National ALS Registry newsletter ; winter 2022
No Description
File Type:
[PDF - 2.85 MB]
File Type:
[PDF - 2.85 MB]

Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript
Cite
CITE Title : Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Published Date : 12/1/17 URL : https://stacks.cdc.gov/view/cdc/50986 United States. Agency for Toxic Substances and Disease Registry. (2017). Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript. United States. Agency for Toxic Substances and Disease Registry. "Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript" (2017) United States. Agency for Toxic Substances and Disease Registry. "Annual Amyotrophic Lateral Sclerosis (ALS) Surveillance Meeting : August 1-2, 2017 summary report meeting transcript" , 2017 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 3.56 MB]
:
United States. Agency for Toxic Substances and Disease Registry.
12/1/17
Description:
Amyotrophic Lateral Sclerosis (ALS) continues to be a mysterious fatal disease with no known cause(s) for approximately 90-95 percent of those diagnos...
File Type:
[PDF - 3.56 MB]
File Type:
[PDF - 3.56 MB]